Latest News about SBIO
Recent news which mentions SBIO
3 Growth-Minded ETFs to Play Fed Rate Pause
June 13, 2023
From ETF Trends
ALPS’ Biotech ETF SBIO Week’s Top Performer
April 24, 2023
From ETF Trends
Biotech ETFs’ Performance Deserves A Look
April 19, 2023
From ETF Trends
From InvestorPlace
Biotech M&A Could Finally Be Ready to Rebound
February 23, 2023
From ETF Trends
Look to SBIO for Biotech Exposure
December 12, 2022
From ETF Trends
Gene Deal Adds New Dimension to Biotech ETF SBIO
November 16, 2022
From ETF Trends
SBIO Rallied While Major Indexes Declined Last Week
October 04, 2022
From ETF Trends
SBIO Outpaced XBI, IBB in Volatile Last Week
September 21, 2022
From ETF Trends
SBIO Was ALPS’ Top Performing ETF in August
September 01, 2022
From ETF Trends
Biotech ETFs Slip After Novavax Cuts 2022 Guidance
August 10, 2022
From ETF Trends
SBIO Rallies on M&A Announcements
August 10, 2022
From ETF Trends
From ETF Trends
From ETF Trends
SBIO Increases on Biotech’s Sustained Rebound
July 20, 2022
From ETF Trends
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
Biotech ETFs Are Making a Comeback
July 05, 2022
From ETF Trends
SBIO Continues Rally on Breakthrough Drug Data
June 29, 2022
From ETF Trends
Size Up SBIO as Biotech Catalysts Emerge
June 01, 2022
From ETF Trends
Betting on Biotech Bear Market Expiration Date
May 25, 2022
From ETF Trends
You Cannot Spell VettaFi Without E-T-F
May 20, 2022
From ETF Trends
Positioning for Biotech Bounceback
April 01, 2022
From ETF Trends
Make Biotech Cash Considerations With SBIO
March 28, 2022
From ETF Trends
Biotech Stocks, ETFs Starting to Look Healthier
March 21, 2022
From ETF Trends
SBIO Is a Good Place to Be for Biotech Innovation
February 28, 2022
From ETF Trends
Some Biotech Stocks Are Now Cheap
February 17, 2022
From ETF Trends
Get Ready for a Biotech ETF Comeback
February 17, 2022
From ETF Trends
2 Unstoppable Growth-Oriented ETFs To Hold for the Long Haul
February 17, 2022
From Motley Fool
Small-Cap Biotech Opportunity Knocks
February 01, 2022
From ETF Trends
Consolidation Could Come Calling for Biotech in 2022
January 05, 2022
From ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.